Holocene Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,831
| Closed | -$634K | – | 888 |
|
|
2025
Q1 | $634K | Sell |
2,831
-8,396
| -75% | -$1.88M | ﹤0.01% | 649 |
|
|
2024
Q4 | $3.68M | Sell |
11,227
-98,213
| -90% | -$32.2M | 0.01% | 443 |
|
|
2024
Q3 | $32.8M | Sell |
109,440
-76,693
| -41% | -$23M | 0.13% | 184 |
|
|
2024
Q2 | $61.3M | Sell |
186,133
-170,875
| -48% | -$56.3M | 0.26% | 118 |
|
|
2024
Q1 | $141M | Buy |
+357,008
| New | +$141M | 0.52% | 66 |
|
|
2023
Q4 | – | Sell |
-17,757
| Closed | -$6.66M | – | 845 |
|
|
2023
Q3 | $6.66M | Buy |
+17,757
| New | +$6.66M | 0.03% | 330 |
|
|
2019
Q3 | – | Sell |
-11,623
| Closed | -$1.46M | – | 856 |
|
|
2019
Q2 | $1.46M | Sell |
11,623
-438
| -4% | -$54.8K | 0.02% | 210 |
|
|
2019
Q1 | $1.33M | Buy |
12,061
+3,665
| +44% | +$404K | 0.02% | 191 |
|
|
2018
Q4 | $823K | Buy |
8,396
+4,255
| +103% | +$417K | 0.01% | 296 |
|
|
2018
Q3 | $511K | Sell |
4,141
-1,105
| -21% | -$136K | 0.01% | 521 |
|
|
2018
Q2 | $521K | Sell |
5,246
-1,320
| -20% | -$131K | 0.01% | 143 |
|
|
2018
Q1 | $580K | Buy |
6,566
+3,902
| +146% | +$345K | 0.01% | 145 |
|
|
2017
Q4 | $263K | Buy |
+2,664
| New | +$263K | 0.01% | 561 |
|